v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Revenue $ 0 $ 0 $ 0 $ 0
Operating expenses:        
Research and development 3,638 4,292 6,711 7,346
General and administrative 2,438 2,579 4,595 5,134
Total operating expenses 6,076 6,871 11,306 12,480
Loss from operations (6,076) (6,871) (11,306) (12,480)
Other (expense) income, net (299) 49 (907) 157
Net loss $ (6,375) $ (6,822) $ (12,213) $ (12,323)
Net loss per share - basic $ (0.1) $ (0.28) $ (0.25) $ (0.53)
Net loss per share - diluted $ (0.1) $ (0.28) $ (0.25) $ (0.53)
Weighted average common shares outstanding - basic 67,084,661 24,187,536 48,821,118 23,057,920
Weighted average common shares outstanding - diluted 67,084,661 24,187,536 48,821,118 23,057,920
Comprehensive loss:        
Net loss $ (6,375) $ (6,822) $ (12,213) $ (12,323)
Other comprehensive loss:        
Unrealized (loss) gain on investments, net of tax of $0 (12) 12 (12) (33)
Foreign currency translation adjustments 5 (24) 5 7
Total other comprehensive loss (7) (12) (7) (26)
Total comprehensive loss $ (6,382) $ (6,834) $ (12,220) $ (12,349)